Contrast-Induced Nephropathy

Contrast-induced nephropathy — increasingly termed contrast-associated acute kidney injury — is an acute decline in kidney function occurring after the intravascular administration of iodinated contrast media. Its causal attribution has been re-examined, because much apparent contrast-associated AKI may reflect the patient's underlying illness and procedure rather than the contrast agent alone.

Definition

Contrast-induced nephropathy is acute kidney injury — a rise in serum creatinine beyond a defined threshold within a few days — that follows intravascular administration of iodinated contrast media and is not attributable to another cause; the broader term contrast-associated AKI reflects uncertainty about direct causation.

Scope

The entry covers the proposed mechanisms, recognized risk factors and risk scoring, the contested question of how much contrast media itself causes AKI, and the evidence on preventive hydration. It is a conceptual reference and does not provide thresholds or protocols for individual patients.

Core questions

• By what mechanisms might iodinated contrast injure the kidney?
• Who is at higher risk, and how is that risk estimated?
• How much of contrast-associated AKI is caused by the contrast itself?
• What does the evidence say about preventive intravenous hydration?

Key concepts

• Iodinated contrast media
• Contrast-associated AKI (terminology shift)
• Renal medullary hypoxia
• Tubular cell toxicity
• Pre-existing chronic kidney disease as a risk factor
• Mehran risk score
• Prophylactic intravenous hydration

Mechanisms

Proposed mechanisms, summarized by Mehran and colleagues, include renal medullary vasoconstriction and hypoxia, direct tubular epithelial toxicity, and oxidative stress, with the osmotic and viscosity properties of contrast media contributing. However, contemporary controlled comparisons suggest that in many patients the kidney injury attributed to contrast reflects concurrent hemodynamic, septic, or procedural insults, which is why the field has moved toward the term contrast-associated AKI to separate association from causation.

Clinical relevance

Contrast-associated AKI is relevant to imaging and interventional procedures because it has been linked to adverse outcomes and because pre-existing kidney disease raises concern; understanding the mechanisms, risk factors, and limits of causal attribution informs how such risk is interpreted. This entry is descriptive and is not a basis for individual decisions about imaging or prophylaxis.

Epidemiology

Reported incidence varies widely with the definition used, the contrast route and volume, the procedure, and especially the baseline kidney function of the population; patients with pre-existing chronic kidney disease, diabetes, and hemodynamic instability are at higher estimated risk, as captured by tools such as the Mehran risk score.

Evidence & guidelines

The 2012 KDIGO guideline addresses prevention of contrast-induced AKI within its AKI framework. The AMACING randomized trial (Nijssen and colleagues, 2017) found prophylactic intravenous hydration to be non-inferior to no prophylaxis in high-risk patients receiving intravascular contrast, contributing to a reassessment of routine prophylaxis. The review by Mehran and colleagues synthesizes mechanisms, risk, and the causation debate.

History

Radiocontrast nephropathy was described as a recognized hazard of iodinated contrast in the era of higher-osmolar agents, and risk scores such as Mehran's (2004) formalized its prediction. As lower-osmolar and iso-osmolar agents came into use and better-controlled studies appeared, the attributable risk was revised downward, the AMACING trial questioned routine hydration prophylaxis, and the terminology shifted toward contrast-associated AKI.

Debates

How much AKI does contrast media actually cause?

Propensity-matched and controlled studies suggest that a substantial portion of post-contrast AKI is due to coexisting illness rather than the agent, so the independent causal contribution of modern contrast media is debated.

Is routine prophylactic hydration warranted in high-risk patients?

The AMACING trial found no benefit of prophylactic intravenous hydration over none in high-risk patients, challenging the prior default of routine prophylaxis.

Key figures

• Roxana Mehran
• Steven D. Weisbord
• Estelle C. Nijssen
• Joachim E. Wildberger

Seminal works

• mehran-2019
• mehran-2004
• nijssen-2017

Frequently asked questions

Why is the term 'contrast-associated AKI' now preferred?

Because controlled studies indicate that much of the kidney injury seen after contrast is driven by the patient's underlying illness and procedure rather than the contrast agent itself, 'contrast-associated' describes the timing without overstating causation.

Who is considered at higher risk for contrast-associated AKI?

Patients with pre-existing chronic kidney disease, diabetes, hemodynamic instability, and exposure to larger contrast volumes are generally estimated to be at higher risk, as reflected in risk-scoring tools.